BioIVT acquires Cypex to boost portfolio
Drug Discovery World
AUGUST 9, 2022
Provider to the life sciences industry BioIVT has acquired enzymes manufacturer Cypex in a bid to enhance its product portfolio. . This technology enables the expression of human drug-metabolizing enzymes in bacteria, without requiring large modifications to the proteins.? .
Let's personalize your content